All News
Filter News
Found 809,032 articles
-
Zoetis Adds Devices for Use in Regenerative Medicine Therapies to its Growing Equine Portfolio
6/1/2021
The range of products are designed to help veterinarians address common - and sometimes debilitating - injuries in horses
-
Sequana Medical Announces First Patient Enrolled in SAHARA DESERTalfapump® DSR study in Heart Failure patients with persistent congestion
6/1/2021
Sequana Medical NV, an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces that the first patient has been enrolled in the SAHARA DESERT study.
-
Centhaquine Improved Shock Index, ARDS, MODS, Reduced Blood Lactate Levels, And 8.8% Absolute Reduction In 28-Day All-Cause Mortality
6/1/2021
Pharmazz, Inc., a biopharmaceutical company focused on developing and commercializing novel therapeutics to treat patients in critical care.
-
Napo EU S.p.A., Jaguar Health’s Italian Subsidiary, Provides Updates on Plans to Pursue Conditional Marketing Authorization in the EU
6/1/2021
Napo EU S.p.A., the Italian subsidiary of Napo Pharmacuticals, Inc., which is a wholly owned subsidiary of Jaguar Health, Inc., provided updates on plans to pursue conditional marketing authorization from the European Medicines Agency for crofelemer, the Company's novel proprietary drug.
-
CBMG Holdings Announces Data from Two CAR-T Clinical Studies Selected for Podium Presentations at ASCO Annual Meeting
6/1/2021
CBMG Holdings, a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, announced the publication of two abstracts of CAR-T therapies for liquid tumors published in conjunction with the 2021 American Society of Clinical Oncology Annual Meeting, to be held June 4-8, 2021.
-
Children's Minnesota NICU at Mercy Hospital expands services to help high-risk mothers deliver closer to home
6/1/2021
The Mother Baby Center, a partnership between Allina Health and Children's Minnesota, announced the expansion of its neonatal intensive care unit services at Mercy Hospital in Coon Rapids, effectively increasing the NICU from Level II to Level III status.
-
argenx Appoints Karl Gubitz as Chief Financial Officer
6/1/2021
argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced the appointment of Mr. Karl Gubitz as Chief Financial Officer.
-
AB Science announces a voluntary hold in the clinical studies of masitinib worldwide
6/1/2021
AB Science SA announced that it has taken the decision to suspend inclusions and treatment initiation in its clinical studies with masitinib worldwide.
-
Jaguar Health & Dragon SPAC Announce Initial Funding of US$10.8 Million into Dragon SPAC
6/1/2021
Equita Group S.p.A., a leading Italian based investment bank, advising Dragon SPAC; Cantor Fitzgerald & Co. advising Jaguar on non-deal related activities
-
Abbott Issues Updated 2021 Outlook
6/1/2021
Abbott announced an update to its financial outlook for the full-year 2021. The updated guidance is due to significantly lower recent and projected COVID-19 diagnostic testing demand.
-
The Urology Care Foundation Encourages Men to Focus on Prevention during Men's Health Month!
6/1/2021
June marks the start of Men's Health Month, a time dedicated to making the health of men throughout the world a priority.
-
NovaBiotics Announces Publication of Data Elucidating NP339's Broad Antifungal Activity in Antimicrobial Agents and Chemotherapy
6/1/2021
Peer reviewed journal article highlights Company's novel antifungal peptide's activity against a broad range of fungal pathogens with no off target cytotoxicity
-
Sanofi provides update on venglustat clinical program
6/1/2021
Sanofi provides update on venglustat clinical program P ARIS – JUNE 1 , 20 21 – A pivotal Phase 2/3 study of venglustat in autosomal dominant polycystic kidney disease (ADPKD) did not meet futility criteria, and the company has halted the clinical program in ADPKD. The safety profile of venglustat remains consistent with previously reported results with more than 500 patients treated to date over a period of up to four years across all clinical programs. Biomarker data from th
-
Applied UV’s Airocide(TM) System Installed in Uruguayan School System
6/1/2021
Applied UV, Inc., an infection control technology company that applies the power of narrow-range ultraviolet light for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its distributor has installed 60 Airocide® units in Colegio Santa Elena, a private school located in Montevideo, Uruguay.
-
Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis
6/1/2021
Akebia Therapeutics, Inc. and its collaborator, Otsuka Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration accepted for filing the New Drug Application for vadadustat for the treatment of anemia due to chronic kidney disease in both adult patients on dialysis and adult patients not on dialysis.
-
Neuronetics Names Todd Cushman as Vice President, Business Development
6/1/2021
With this new appointment, the market leader in transcranial magnetic stimulation will continue expanding treatment access for patients with Major Depressive Disorder
-
Shineco, Inc. Announces It’s Unaware of Reason for Stock Volatility
6/1/2021
Shineco, Inc., a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, announced in response to unusual market activity, and after speaking with its officers, directors, major shareholders and other relevant persons, that it is unaware of the reason behind recent stock price volatility.
-
Santhera and ReveraGen Announce Positive and Statistically Highly Significant Topline Results with Vamorolone in Pivotal VISION-DMD Study
6/1/2021
Santhera will hold a conference call / webcast at 16:00 CEST, 15:00 BST, 10:00 EDT. Details are at the end of this statement.
-
ALR Technologies Inc. Moves to Singapore
6/1/2021
ALR Technologies Inc. announced that it is taking steps to redomicile the Company to Singapore.
-
FDA Launches Challenge to Spur Development of Affordable Traceability Tools as Part of Broader Food Safety Efforts
6/1/2021
The U.S. Food and Drug Administration launched a challenge to spur the development of affordable, tech-enabled traceability tools to help protect people and animals from contaminated foods by enabling the rapid identification of their sources and helping remove them from the marketplace as quickly as possible.